Over the last 7 days, the market has remained flat, while over a longer term, it has risen 18% in the past 12 months with earnings forecast to grow by 17% annually. For investors willing to explore beyond well-known stocks, penny stocks—often representing smaller or newer companies—can present intriguing opportunities. Despite being a somewhat outdated term, these investments remain relevant and can offer growth potential when supported by strong balance sheets and solid fundamentals.
Let's dive into some prime choices out of the screener.
Simply Wall St Financial Health Rating: ★★★★★★
Overview: 1stdibs.Com, Inc. operates an online marketplace for luxury design products worldwide and has a market cap of $154.63 million.
Operations: The company generates $90.65 million in revenue from its online retail segment.
Market Cap: $154.63M
1stdibs.Com, Inc. has shown resilience in the penny stock arena with a market cap of US$154.63 million and revenue of US$90.65 million from its online retail segment. Despite being unprofitable, it has reduced losses significantly over the past five years by 14.8% annually and remains debt-free, ensuring financial stability with short-term assets covering both short- and long-term liabilities comfortably. Recent strategic initiatives include a partnership with Topsort to enhance monetization through advanced commerce media infrastructure, aligning with its premium marketplace model focused on discovery and curation—an essential move for long-term growth without sacrificing customer experience.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Patriot National Bancorp, Inc. operates as the holding company for Patriot Bank, N.A., with a market cap of approximately $134.83 million.
Operations: The company generates its revenue primarily through its Community Banking segment, which reported $39.44 million in revenue.
Market Cap: $134.83M
Patriot National Bancorp, Inc. has faced challenges typical of penny stocks, with recent earnings showing net interest income of US$8.96 million for Q2 2026, an improvement from the previous year. However, it remains unprofitable with a negative return on equity and losses increasing by 56.4% annually over five years. The company was recently dropped from several Russell indexes but added to the Russell Microcap Value Benchmark Index, reflecting its volatile market position. Its management and board are relatively inexperienced with short tenures, which could impact strategic direction in a competitive banking sector landscape.
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Health Catalyst, Inc. offers data and analytics technology and services to U.S. healthcare organizations with a market cap of approximately $127.18 million.
Operations: The company's revenue is derived from two primary segments: Technology, which generated $202.18 million, and Professional Services, contributing $90.06 million.
Market Cap: $127.18M
Health Catalyst, Inc. operates within the penny stock landscape with a market cap of approximately US$127.18 million, and its financials reflect both opportunities and challenges. Despite generating US$141.24 million in revenue for the first half of 2026, it remains unprofitable with increasing net losses and a negative return on equity. The company has been removed from several Russell indexes, indicating market volatility concerns. However, Health Catalyst's short-term assets exceed liabilities, providing some financial stability alongside a positive cash runway projected for over three years due to growing free cash flow despite high debt levels and an inexperienced board of directors.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com